Precision Medicine Market Size, Share & Industry Analysis, By Product (Drugs, Devices, Software), By Type (Diagnostic {Genetic Tests [Predictive & Presymptomatic Tests, Carrier Testing, Prenatal & Newborn Screening], Biomarker Tests [Screening, Recurrence Monitoring, & Therapy Selection]}, Therapeutics {Monoclonal Antibodies, Gene Therapy, Cell Therapy}, & Research), By Indication (Oncology, Neurology/ Psychiatry, Immunology), By End-User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic Laboratories, Contract Research Organizations), & Regional Forecast, 2026-2034

Last Updated: January 19, 2026 | Format: PDF | Report ID: FBI110463

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Market Scope
2. Market Segmentation
3. Market Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Chronic Diseases, By Key Countries/ Regions, 2025
2. Percentage of FDA Approved Precision Medicine Drugs, 2021-2025
3. New Product Launches/ Approvals, By Key Players
4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
5. Pipeline Analysis
6. Impact of COVID-19 in the Market
Global Precision Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Drugs
  2. Devices
  3. Software
2. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. Genetic Tests
      1. Predictive & Presymptomatic Tests
      2. Carrier Testing
      3. Prenatal & Newborn Screening
      4. Others
    2. Biomarker Tests
      1. Screening
      2. Recurrence Monitoring
      3. Therapy Selection
    3. Others
  2. Therapeutics
    1. Monoclonal Antibodies
    2. Gene Therapy
    3. Cell Therapy
    4. Others
  3. Research
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Neurology/ Psychiatry
  3. Immunology
  4. Cardiology
  5. Endocrinology
  6. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. Diagnostic Laboratories
  3. Contract Research Organizations (CROs)
  4. Others
5. Market Analysis, Insights and Forecast – By Geography
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Precision Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Drugs
  2. Devices
  3. Software
2. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. Genetic Tests
      1. Predictive & Presymptomatic Tests
      2. Carrier Testing
      3. Prenatal & Newborn Screening
      4. Others
    2. Biomarker Tests
      1. Screening
      2. Recurrence Monitoring
      3. Therapy Selection
    3. Others
  2. Therapeutics
    1. Monoclonal Antibodies
    2. Gene Therapy
    3. Cell Therapy
    4. Others
  3. Research
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Neurology/ Psychiatry
  3. Immunology
  4. Cardiology
  5. Endocrinology
  6. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. Diagnostic Laboratories
  3. Contract Research Organizations (CROs)
  4. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Precision Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Drugs
  2. Devices
  3. Software
2. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. Genetic Tests
      1. Predictive & Presymptomatic Tests
      2. Carrier Testing
      3. Prenatal & Newborn Screening
      4. Others
    2. Biomarker Tests
      1. Screening
      2. Recurrence Monitoring
      3. Therapy Selection
    3. Others
  2. Therapeutics
    1. Monoclonal Antibodies
    2. Gene Therapy
    3. Cell Therapy
    4. Others
  3. Research
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Neurology/ Psychiatry
  3. Immunology
  4. Cardiology
  5. Endocrinology
  6. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. Diagnostic Laboratories
  3. Contract Research Organizations (CROs)
  4. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Precision Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Drugs
  2. Devices
  3. Software
2. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. Genetic Tests
      1. Predictive & Presymptomatic Tests
      2. Carrier Testing
      3. Prenatal & Newborn Screening
      4. Others
    2. Biomarker Tests
      1. Screening
      2. Recurrence Monitoring
      3. Therapy Selection
    3. Others
  2. Therapeutics
    1. Monoclonal Antibodies
    2. Gene Therapy
    3. Cell Therapy
    4. Others
  3. Research
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Neurology/ Psychiatry
  3. Immunology
  4. Cardiology
  5. Endocrinology
  6. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. Diagnostic Laboratories
  3. Contract Research Organizations (CROs)
  4. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. South East Asia
  6. Rest of Asia Pacific
Latin America Precision Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Drugs
  2. Devices
  3. Software
2. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. Genetic Tests
      1. Predictive & Presymptomatic Tests
      2. Carrier Testing
      3. Prenatal & Newborn Screening
      4. Others
    2. Biomarker Tests
      1. Screening
      2. Recurrence Monitoring
      3. Therapy Selection
    3. Others
  2. Therapeutics
    1. Monoclonal Antibodies
    2. Gene Therapy
    3. Cell Therapy
    4. Others
  3. Research
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Neurology/ Psychiatry
  3. Immunology
  4. Cardiology
  5. Endocrinology
  6. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. Diagnostic Laboratories
  3. Contract Research Organizations (CROs)
  4. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Precision Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Drugs
  2. Devices
  3. Software
2. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. Genetic Tests
      1. Predictive & Presymptomatic Tests
      2. Carrier Testing
      3. Prenatal & Newborn Screening
      4. Others
    2. Biomarker Tests
      1. Screening
      2. Recurrence Monitoring
      3. Therapy Selection
    3. Others
  2. Therapeutics
    1. Monoclonal Antibodies
    2. Gene Therapy
    3. Cell Therapy
    4. Others
  3. Research
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Neurology/ Psychiatry
  3. Immunology
  4. Cardiology
  5. Endocrinology
  6. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. Diagnostic Laboratories
  3. Contract Research Organizations (CROs)
  4. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. Illumina, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Agilent Technologies, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Thermo Fisher Scientific Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Pfizer Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Novartis AG
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Bristol-Myers Squibb Company
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Nucleai, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Precision Medicine Group, LLC.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. AstraZeneca
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. QIAGEN
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  11. Abbott
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  12. Koninklijke Philips N.V.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  13. IBM Life Sciences
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Market Scope
2. Market Segmentation
3. Market Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Chronic Diseases, By Key Countries/ Regions, 2025
2. Percentage of FDA Approved Precision Medicine Drugs, 2021-2025
3. New Product Launches/ Approvals, By Key Players
4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
5. Pipeline Analysis
6. Impact of COVID-19 in the Market
Global Precision Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Drugs
  2. Devices
  3. Software
2. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. Genetic Tests
      1. Predictive & Presymptomatic Tests
      2. Carrier Testing
      3. Prenatal & Newborn Screening
      4. Others
    2. Biomarker Tests
      1. Screening
      2. Recurrence Monitoring
      3. Therapy Selection
    3. Others
  2. Therapeutics
    1. Monoclonal Antibodies
    2. Gene Therapy
    3. Cell Therapy
    4. Others
  3. Research
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Neurology/ Psychiatry
  3. Immunology
  4. Cardiology
  5. Endocrinology
  6. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. Diagnostic Laboratories
  3. Contract Research Organizations (CROs)
  4. Others
5. Market Analysis, Insights and Forecast – By Geography
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Precision Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Drugs
  2. Devices
  3. Software
2. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. Genetic Tests
      1. Predictive & Presymptomatic Tests
      2. Carrier Testing
      3. Prenatal & Newborn Screening
      4. Others
    2. Biomarker Tests
      1. Screening
      2. Recurrence Monitoring
      3. Therapy Selection
    3. Others
  2. Therapeutics
    1. Monoclonal Antibodies
    2. Gene Therapy
    3. Cell Therapy
    4. Others
  3. Research
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Neurology/ Psychiatry
  3. Immunology
  4. Cardiology
  5. Endocrinology
  6. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. Diagnostic Laboratories
  3. Contract Research Organizations (CROs)
  4. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Precision Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Drugs
  2. Devices
  3. Software
2. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. Genetic Tests
      1. Predictive & Presymptomatic Tests
      2. Carrier Testing
      3. Prenatal & Newborn Screening
      4. Others
    2. Biomarker Tests
      1. Screening
      2. Recurrence Monitoring
      3. Therapy Selection
    3. Others
  2. Therapeutics
    1. Monoclonal Antibodies
    2. Gene Therapy
    3. Cell Therapy
    4. Others
  3. Research
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Neurology/ Psychiatry
  3. Immunology
  4. Cardiology
  5. Endocrinology
  6. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. Diagnostic Laboratories
  3. Contract Research Organizations (CROs)
  4. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Precision Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Drugs
  2. Devices
  3. Software
2. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. Genetic Tests
      1. Predictive & Presymptomatic Tests
      2. Carrier Testing
      3. Prenatal & Newborn Screening
      4. Others
    2. Biomarker Tests
      1. Screening
      2. Recurrence Monitoring
      3. Therapy Selection
    3. Others
  2. Therapeutics
    1. Monoclonal Antibodies
    2. Gene Therapy
    3. Cell Therapy
    4. Others
  3. Research
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Neurology/ Psychiatry
  3. Immunology
  4. Cardiology
  5. Endocrinology
  6. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. Diagnostic Laboratories
  3. Contract Research Organizations (CROs)
  4. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. South East Asia
  6. Rest of Asia Pacific
Latin America Precision Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Drugs
  2. Devices
  3. Software
2. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. Genetic Tests
      1. Predictive & Presymptomatic Tests
      2. Carrier Testing
      3. Prenatal & Newborn Screening
      4. Others
    2. Biomarker Tests
      1. Screening
      2. Recurrence Monitoring
      3. Therapy Selection
    3. Others
  2. Therapeutics
    1. Monoclonal Antibodies
    2. Gene Therapy
    3. Cell Therapy
    4. Others
  3. Research
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Neurology/ Psychiatry
  3. Immunology
  4. Cardiology
  5. Endocrinology
  6. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. Diagnostic Laboratories
  3. Contract Research Organizations (CROs)
  4. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Precision Medicine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Drugs
  2. Devices
  3. Software
2. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic
    1. Genetic Tests
      1. Predictive & Presymptomatic Tests
      2. Carrier Testing
      3. Prenatal & Newborn Screening
      4. Others
    2. Biomarker Tests
      1. Screening
      2. Recurrence Monitoring
      3. Therapy Selection
    3. Others
  2. Therapeutics
    1. Monoclonal Antibodies
    2. Gene Therapy
    3. Cell Therapy
    4. Others
  3. Research
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Neurology/ Psychiatry
  3. Immunology
  4. Cardiology
  5. Endocrinology
  6. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical & Biopharmaceutical Companies
  2. Diagnostic Laboratories
  3. Contract Research Organizations (CROs)
  4. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. Illumina, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Agilent Technologies, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Thermo Fisher Scientific Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Pfizer Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Novartis AG
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Bristol-Myers Squibb Company
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Nucleai, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Precision Medicine Group, LLC.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. AstraZeneca
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. QIAGEN
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  11. Abbott
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  12. Koninklijke Philips N.V.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  13. IBM Life Sciences
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Precision Medicine Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Precision Medicine Market Value Share (%), by Product, 2025 & 2034

Figure 3: Global Precision Medicine Market Value Share (%), by Type, 2025 & 2034

Figure 4: Global Precision Medicine Market Value Share (%), by Indication, 2025 & 2034

Figure 5: Global Precision Medicine Market Value Share (%), by End User, 2025 & 2034

Figure 6: Global Precision Medicine Market Value (USD billion), by Region, 2025 & 2034

Figure 7: North America Precision Medicine Market Value (USD billion), by Product, 2025 & 2034

Figure 8: North America Precision Medicine Market Value Share (%), by Product, 2025

Figure 9: North America Precision Medicine Market Value (USD billion), by Type, 2025 & 2034

Figure 10: North America Precision Medicine Market Value Share (%), by Type, 2025

Figure 11: North America Precision Medicine Market Value (USD billion), by Indication, 2025 & 2034

Figure 12: North America Precision Medicine Market Value Share (%), by Indication, 2025

Figure 13: North America Precision Medicine Market Value (USD billion), by End User, 2025 & 2034

Figure 14: North America Precision Medicine Market Value Share (%), by End User, 2025

Figure 15: North America Precision Medicine Market Value (USD billion), By Country, 2025 & 2034

Figure 16: North America Precision Medicine Market Value Share (%), By Country, 2025

Figure 17: Europe Precision Medicine Market Value (USD billion), by Product, 2025 & 2034

Figure 18: Europe Precision Medicine Market Value Share (%), by Product, 2025

Figure 19: Europe Precision Medicine Market Value (USD billion), by Type, 2025 & 2034

Figure 20: Europe Precision Medicine Market Value Share (%), by Type, 2025

Figure 21: Europe Precision Medicine Market Value (USD billion), by Indication, 2025 & 2034

Figure 22: Europe Precision Medicine Market Value Share (%), by Indication, 2025

Figure 23: Europe Precision Medicine Market Value (USD billion), by End User, 2025 & 2034

Figure 24: Europe Precision Medicine Market Value Share (%), by End User, 2025

Figure 25: Europe Precision Medicine Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 26: Europe Precision Medicine Market Value Share (%), By Country/ Sub-region, 2025

Figure 27: Asia Pacific Precision Medicine Market Value (USD billion), by Product, 2025 & 2034

Figure 28: Asia Pacific Precision Medicine Market Value Share (%), by Product, 2025

Figure 29: Asia Pacific Precision Medicine Market Value (USD billion), by Type, 2025 & 2034

Figure 30: Asia Pacific Precision Medicine Market Value Share (%), by Type, 2025

Figure 31: Asia Pacific Precision Medicine Market Value (USD billion), by Indication, 2025 & 2034

Figure 32: Asia Pacific Precision Medicine Market Value Share (%), by Indication, 2025

Figure 33: Asia Pacific Precision Medicine Market Value (USD billion), by End User, 2025 & 2034

Figure 34: Asia Pacific Precision Medicine Market Value Share (%), by End User, 2025

Figure 35: Asia Pacific Precision Medicine Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 36: Asia Pacific Precision Medicine Market Value Share (%), By Country/ Sub-region, 2025

Figure 37: Latin America Precision Medicine Market Value (USD billion), by Product, 2025 & 2034

Figure 38: Latin America Precision Medicine Market Value Share (%), by Product, 2025

Figure 39: Latin America Precision Medicine Market Value (USD billion), by Type, 2025 & 2034

Figure 40: Latin America Precision Medicine Market Value Share (%), by Type, 2025

Figure 41: Latin America Precision Medicine Market Value (USD billion), by Indication, 2025 & 2034

Figure 42: Latin America Precision Medicine Market Value Share (%), by Indication, 2025

Figure 43: Latin America Precision Medicine Market Value (USD billion), by End User, 2025 & 2034

Figure 44: Latin America Precision Medicine Market Value Share (%), by End User, 2025

Figure 45: Latin America Precision Medicine Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 46: Latin America Precision Medicine Market Value Share (%), By Country/ Sub-region, 2025

Figure 47: Middle East & Africa Precision Medicine Market Value (USD billion), by Product, 2025 & 2034

Figure 48: Middle East & Africa Precision Medicine Market Value Share (%), by Product, 2025

Figure 49: Middle East & Africa Precision Medicine Market Value (USD billion), by Type, 2025 & 2034

Figure 50: Middle East & Africa Precision Medicine Market Value Share (%), by Type, 2025

Figure 51: Middle East & Africa Precision Medicine Market Value (USD billion), by Indication, 2025 & 2034

Figure 52: Middle East & Africa Precision Medicine Market Value Share (%), by Indication, 2025

Figure 53: Middle East & Africa Precision Medicine Market Value (USD billion), by End User, 2025 & 2034

Figure 54: Middle East & Africa Precision Medicine Market Value Share (%), by End User, 2025

Figure 55: Middle East & Africa Precision Medicine Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 56: Middle East & Africa Precision Medicine Market Value Share (%), By Country/ Sub-region, 2025

Figure 57: Global Precision Medicine Market Share (%), By Company, 2025

List of Tables

Table 1: Global Precision Medicine Market Revenue (USD billion) Forecast, by Product, 2021–2034

Table 2: Global Precision Medicine Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 3: Global Precision Medicine Market Revenue (USD billion) Forecast, by Diagnostics, 2021-2034

Table 4: Global Precision Medicine Market Revenue (USD billion) Forecast, by Biomarker Test, 2021-2034

Table 5: Global Precision Medicine Market Revenue (USD billion) Forecast, by Genetic Test, 2021-2034

Table 6: Global Precision Medicine Market Revenue (USD billion) Forecast, by Therapeutics, 2021-2034

Table 7: Global Precision Medicine Market Revenue (USD billion) Forecast, by Indication, 2021–2034

Table 8: Global Precision Medicine Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 9: Global Precision Medicine Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 10: North America Precision Medicine Market Revenue (USD billion) Forecast, by Product, 2021-2034

Table 11: North America Precision Medicine Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 12: North America Precision Medicine Market Revenue (USD billion) Forecast, by Diagnostics, 2021-2034

Table 13: North America Precision Medicine Market Revenue (USD billion) Forecast, by Biomarker Test, 2021-2034

Table 14: North America Precision Medicine Market Revenue (USD billion) Forecast, by Genetic Test, 2021-2034

Table 15: North America Precision Medicine Market Revenue (USD billion) Forecast, by Therapeutics, 2021-2034

Table 16: North America Precision Medicine Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 17: North America Precision Medicine Market Revenue (USD billion) Forecast, by End User, 2021-2034

Table 18: North America Precision Medicine Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 19: Europe Precision Medicine Market Revenue (USD billion) Forecast, by Product, 2021-2034

Table 20: Europe Precision Medicine Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 21: Europe Precision Medicine Market Revenue (USD billion) Forecast, by Diagnostics, 2021-2034

Table 22: Europe Precision Medicine Market Revenue (USD billion) Forecast, by Biomarker Test, 2021-2034

Table 23: Europe Precision Medicine Market Revenue (USD billion) Forecast, by Genetic Test, 2021-2034

Table 24: Europe Precision Medicine Market Revenue (USD billion) Forecast, by Therapeutics, 2021-2034

Table 25: Europe Precision Medicine Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 26: Europe Precision Medicine Market Revenue (USD billion) Forecast, by End User, 2021-2034

Table 27: Europe Precision Medicine Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 28: Asia Pacific Precision Medicine Market Revenue (USD billion) Forecast, by Product, 2021-2034

Table 29: Asia Pacific Precision Medicine Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 30: Asia Pacific Precision Medicine Market Revenue (USD billion) Forecast, by Diagnostics, 2021-2034

Table 31: Asia Pacific Precision Medicine Market Revenue (USD billion) Forecast, by Biomarker Test, 2021-2034

Table 32: Asia Pacific Precision Medicine Market Revenue (USD billion) Forecast, by Genetic Test, 2021-2034

Table 33: Asia Pacific Precision Medicine Market Revenue (USD billion) Forecast, by Therapeutics, 2021-2034

Table 34: Asia Pacific Precision Medicine Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 35: Asia Pacific Precision Medicine Market Revenue (USD billion) Forecast, by End User, 2021-2034

Table 36: Asia Pacific Precision Medicine Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 37: Latin America Precision Medicine Market Revenue (USD billion) Forecast, by Product, 2021-2034

Table 38: Latin America Precision Medicine Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 39: Latin America Precision Medicine Market Revenue (USD billion) Forecast, by Diagnostics, 2021-2034

Table 40: Latin America Precision Medicine Market Revenue (USD billion) Forecast, by Biomarker Test, 2021-2034

Table 41: Latin America Precision Medicine Market Revenue (USD billion) Forecast, by Genetic Test, 2021-2034

Table 42: Latin America Precision Medicine Market Revenue (USD billion) Forecast, by Therapeutics, 2021-2034

Table 43: Latin America Precision Medicine Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 44: Latin America Precision Medicine Market Revenue (USD billion) Forecast, by End User, 2021-2034

Table 45: Latin America Precision Medicine Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 46: Middle East & Africa Precision Medicine Market Revenue (USD billion) Forecast, by Product, 2021-2034

Table 47: Middle East & Africa Precision Medicine Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 48: Middle East & Africa Precision Medicine Market Revenue (USD billion) Forecast, by Diagnostics, 2021-2034

Table 49: Middle East & Africa Precision Medicine Market Revenue (USD billion) Forecast, by Biomarker Test, 2021-2034

Table 50: Middle East & Africa Precision Medicine Market Revenue (USD billion) Forecast, by Genetic Test, 2021-2034

Table 51: Middle East & Africa Precision Medicine Market Revenue (USD billion) Forecast, by Therapeutics, 2021-2034

Table 52: Middle East & Africa Precision Medicine Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 53: Middle East & Africa Precision Medicine Market Revenue (USD billion) Forecast, by End User, 2021-2034

Table 54: Middle East & Africa Precision Medicine Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 181

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com